Endless Biotech and Quest Join Forces in Strategic Marketing Initiatives to Enhance Cannabis Operations

Endless Biotech and Quest Join Forces in Strategic Marketing Initiatives to Enhance Cannabis Operations

Endless Biotech partners with QUEST to enhance cannabis operations using advanced dehumidification, aiming to improve efficiency, quality, and market reach.

Tulsa, OK – [Date] – Endless Biotech, renowned for its scientific approach to cannabis cultivation, announces a strategic marketing campaign partnership with QUEST, a leader in dehumidification technology. This collaboration aims to expand market reach and enhance operational efficiency through innovative solutions.

Endless Biotech has established itself as one of the most scientifically advanced cannabis operations in the country, leveraging pioneering research and testing methodologies to ensure the highest standards of cultivation. After extensive evaluation, Endless Biotech chose QUEST dehumidifiers as the preferred solution for its entire operation. Known for their industry-leading technology, QUEST dehumidifiers offer superior performance and reliability, aligning perfectly with Endless Biotech's commitment to excellence.

Chief Executive Officer Travis Dahm expressed enthusiasm about the partnership, stating, "We are thrilled to collaborate with QUEST to optimize our cultivation environment. Endless Biotech's dedication to scientific precision in cannabis cultivation aligns seamlessly with QUEST's innovative dehumidification solutions. This partnership allows us to enhance our operational efficiency and maintain the stringent quality standards that define our brand."

The marketing campaigns will highlight the strategic alignment between Endless Biotech and QUEST, showcasing the benefits of QUEST's dehumidification technology in optimizing growth conditions for cannabis cultivation. This initiative aims to educate the industry about the combined expertise of both companies and their shared commitment to advancing the cannabis sector through innovation and excellence.

"We are proud to support Endless Biotech in their mission to deliver pharmaceutical-grade cannabis tissue culture services," said a spokesperson from QUEST. "Our partnership highlights our mutual dedication to pushing the boundaries of what is possible in cannabis cultivation. Together, we look forward to driving positive outcomes and setting new standards for excellence in the industry."

The partnership between Endless Biotech and QUEST represents a strategic move to leverage cutting-edge technology for enhanced operational outcomes and underscores both companies' leadership in their respective fields. This collaboration promises to deliver significant value to the cannabis industry, setting a precedent for innovation and excellence.

About Endless Biotech

Endless Biotech specializes in pharmaceutical-grade tissue cultures, clone genetics, genetic preservation, disease cleanup, and virus testing. With a mission to provide disease- and pest-free cannabis plants, Endless combines pioneering science and cutting-edge technology to serve grow operations globally. The company’s team includes world-renowned scientists and researchers dedicated to advancing the cannabis industry.

About Quest

Quest is a leading provider of advanced dehumidification solutions, specializing in creating optimal environmental conditions for various industries, including cannabis cultivation. Known for their cutting-edge technology and commitment to innovation, Quest dehumidifiers are trusted worldwide to maintain precise humidity levels essential for maximizing crop yields and quality. With a focus on reliability, efficiency, and performance, Quest continues to drive advancements in environmental control systems, supporting growers in achieving consistent and exceptional results across their operations.

Forward Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the launch of Cross Marketing & Strategic Partners initiatives. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Securities & Exchange Committee (SEC) has not reviewed, approved or disapproved the content of this news release.